187 related articles for article (PubMed ID: 20846507)
1. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
[TBL] [Abstract][Full Text] [Related]
2. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats.
Genovese RF; Sun W; Johnson CC; Ditargiani RC; Doctor BP; Saxena A
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):428-34. PubMed ID: 20050840
[TBL] [Abstract][Full Text] [Related]
3. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys.
Lenz DE; Maxwell DM; Koplovitz I; Clark CR; Capacio BR; Cerasoli DM; Federko JM; Luo C; Saxena A; Doctor BP; Olson C
Chem Biol Interact; 2005 Dec; 157-158():205-10. PubMed ID: 16289064
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs.
Sun W; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():428-9. PubMed ID: 16429577
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
6. Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.
Lenz DE; Clarkson ED; Schulz SM; Cerasoli DM
Chem Biol Interact; 2010 Sep; 187(1-3):249-52. PubMed ID: 20513442
[TBL] [Abstract][Full Text] [Related]
7. Effect of polyethylene glycol conjugation on the circulatory stability of plasma-derived human butyrylcholinesterase in mice.
Sun W; Luo C; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):172-6. PubMed ID: 23220586
[TBL] [Abstract][Full Text] [Related]
8. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
[TBL] [Abstract][Full Text] [Related]
9. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Saxena A; Sun W; Luo C; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Sun W; Doctor BP; Lenz DE; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of human serum butyrylcholinesterase and nerve agents are behaviorally safe in rhesus macaques.
Saxena A; Myers TM; Sipos ML
Chem Biol Interact; 2021 Aug; 344():109499. PubMed ID: 33961835
[TBL] [Abstract][Full Text] [Related]
12. Repeated low-dose exposures to sarin, soman, or VX affect acoustic startle in guinea pigs.
Smith CD; Lee RB; Moran AV; Sipos ML
Neurotoxicol Teratol; 2016; 54():36-45. PubMed ID: 26829110
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with human serum butyrylcholinesterase protects Göttingen minipigs exposed to a lethal high-dose of sarin vapor.
Saxena A; Hastings NB; Sun W; Dabisch PA; Hulet SW; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2015 Aug; 238():161-9. PubMed ID: 26145887
[TBL] [Abstract][Full Text] [Related]
14. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication.
Cerasoli DM; Armstrong SJ; Reeves TE; Hodgins SM; Kasten SA; Lee-Stubbs RB; Cadieux CL; Otto TC; Capacio BR; Lenz DE
Biochem Pharmacol; 2020 Jan; 171():113670. PubMed ID: 31628910
[TBL] [Abstract][Full Text] [Related]
17. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam.
Clarkson ED; Schulz SM; Railer RF; Smith KH
Toxicol Lett; 2012 Aug; 212(3):282-7. PubMed ID: 22698813
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Biochem Pharmacol; 2011 Dec; 82(12):1984-93. PubMed ID: 21968035
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
